Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMGX, currently $3.50 -- Ignore unavailable to you. Want to Upgrade?

To: Jay Morrison who wrote (500)	11/12/1997 7:36:00 AM
From: Constance K. Landis	Read Replies (1) \| Respond to of 665

Constance mumbled: <<How can you possibly even consider comparing IMGX to these other stocks?>> Because IMGX is a stock that is very similar to those stocks. You should re-read everything written previously so that you better understand the details. Your entire post demonstrates that you do not. Similar, yes they are both software companies, yes they have similar market caps. As for accelerated share value and profitability, clearly there is little to compare. <<No analyst worth a damn is going to promote this stock or for that matter any stock that perpetuates continued losses.>> That is not true. I have seen many companies perpetuate losses and be covered. Apple comes to mind. What a grand example. I only wish that IMGX will have as many profitable 1/4's. Apple remains "covered" due to their continued impact on personal computing and due to their historical growth. You seem obsessed to compare "apples(no pun intended) to lemons". <<Even mentioning it in the same vein with Microsoft is absolutely ridiculous. Come back to reality.>> Once again, you missed the point of WHY it was mentioned. MSFT and the others were mentioned to demonstrate that software companies can trade anywhere between 5x sales to as high as 10x sales. MSFT is currently 10x sales. FILE is currently 5.8x sales, but has been as high as 10x sales. There is nothing that is special about how Microsoft is judged. It is priced exactly the same as other software companies. By p/e and by revenue. They are simply the biggest. Using MSFT as an example is logical assuming that IMGX is a growth story. Missed the point, indeed. You were the one who stated "But this is all wishful thinking on my part". Again, your assumption that IMGX is "a growth story" is unsupported by real data. You failed to understand the basic concept that domestic (non-Dorotech) sales are growing and growing quite well. Dorotech will be gone by next month in my opinion. Q4 results will likely be stated in terms of IMGX only without Dorotech. US revenue last quarter was $6.5 million. It will at least be $7.4 million next quarter (Zannett target) and is likely to be around $8 million. That is a growth company that deserves to be rated as other software growth companies. What else does your crystal ball tell you? You continue to project based on assumptions. What makes you think they will unload Dorotech next month? An attempt to improve year end numbers? What new excuses for failed performance will they use without Dorotech?

To: Jay Morrison who wrote (500)	11/12/1997 8:10:00 AM
From: Constance K. Landis	Read Replies (1) \| Respond to of 665

<<Leto talked last year about increasing their sales force and ramping up a marketing effort. Short of hiring the guy associated with government contracts what have they done?>> They hired 6 new sales people in the past quarter. If you had bothered to listen to the conference call you would understand all of this. Would have loved to have heard the conference call but due to the dismall performance of this stock I am compelled to work for a living. <<Yeah, yeah I know he's now generating sales in the government sector to the tune of a projected $3.5 million. But again, be realistic. That is less than 1/10 of what they need (in your estimation) to become profitable. Where is the remaining $37 million coming from?>> According to the last conference call (which you clearly missed) the pipeline for the government side is $17.5 million, of which, $3 million could happen at any moment. This is a part of the overall $81 million pipeline. The $81 million pipeline is where the revenue will come from. Rougly half of the pipeline will get converted to revenue. I think the lasted analyst estimate was $43 million in revenue for 1998. (US sales only) That is a profitable year by about 5 cents per share. Here we go again with this "pipeline" talk. Tell me, why don't I see this term as widely utilized with other companies? Let's talk "real" sales, not "pipedreams". <<As for their stocks value, why does it continue to stagnate and as it did yesterday, fall with little trade volume?>> It is stagnating because currently IMGX is part of Dorotech and when the US side has a good quarter, nobody notices since Dorotech clouds the picture. THAT is why Dorotech is history. Once it is gone, all results can be stated compared to the previous year for US sales only. Those comparisons will make it easier for the growth picture to be seen. Let me see now, Dorotech will be gone next month. Revenues from it's sale will provide capital for 98. The pipeline will kick in approximately $8 to 10 million in 1/4ly sales. All of this now laid out when will it's stock value begin it's climb? Or is the crystal ball still cloudy on this subject? <<Leto needs to address this challange or be lanquished for someone else who can.>> That is the most rediculous statement you have made to date. Leto is the only reason the company is currently getting it's act together. I can tell you that Kessick has nothing to do with it. I suggest you look more closely at the situation before you start spouting such nonsense in the future. Kessick is a puppet. He simple fronts for whatever management wishes him to portray. You are right, Leto is the "man". You have put alot of faith in him. For both of us I hope your judgement isn't tainted.